Scott Eliasof

Scott Eliasof is the director of the Chemical Biology platform at the Broad Institute. This platform develops and uses new and existing technologies to harness the power of synthetic chemistry to discover and elucidate molecular pathways fundamental to cell and disease biology.

Scott manages five teams whose work impacts both the Chemical Biology program as well as the Broad Institute as a whole: an automation team, a high-throughput screening team, an analytical chemistry team, a synthetic chemistry team and a cheminformatics team.

Prior to joining Broad, Scott was a senior scientist at Millennium Pharmaceuticals where he managed a team of molecular biologists, neuroscientists and bioinformatics specialists for a large genomics-based drug discovery program. Before that, Scott was at Neurocrine Biosciences, where he played a key role in the exploration of glutamate transporters in the field of stroke and neurological disorders.

Scott received his B.S. in 1983 from MIT in electrical engineering, Ph.D. from the University of California at Berkeley in neuroscience, and completed his postdoctoral fellowship at the Vollum Institute in Portland, Oregon.